?????????????
?FDA?21????????????????????????????????Vytorin????????????????????????????????????Early Communication???????????????? (³¤¤òÆÉ¤à…)
?FDA?21????????????????????????????????Vytorin????????????????????????????????????Early Communication???????????????? (³¤¤òÆÉ¤à…)
??FDA?8????????????????????????????????????????????? (³¤¤òÆÉ¤à…)
?MHRA?????????5????????????????????????????? Public consultation??????TOPICS 2007.6.30???????????????????????????POM???????????P????????????????????????? (³¤¤òÆÉ¤à…)
???????????????????TGA??1?????”Australian Adverse Drug Reactions Bulletin “??????B6???????????????????????????eripheral neuropathy?????????????????????????? (³¤¤òÆÉ¤à…)
?7?24???????????????20???1???????????????????4???????????????????????????????????????????????? (³¤¤òÆÉ¤à…)
??????????http://www.emea.europa.eu/??EMEA:European Medicines Agency???????????CHMP?Committee for Human Medicinal Products??24???????????????????????????????????????????????????????????????????????????????????????????????? (³¤¤òÆÉ¤à…)
???NICE?23????????respiratory tract infections??????????????????????????????????? (³¤¤òÆÉ¤à…)
??FDA?8?????????????????????????????????????????????????????????tendinitis??????tendon rupture????????????????????????????????????????????????“medication guide”???????????????? (³¤¤òÆÉ¤à…)
??????2006?3???????????????????????????????????????????????????????????????????????Department of Health???1????????????????????????????????????????????????????????? (³¤¤òÆÉ¤à…)
???????19??????dementia???????????????????????????????Transforming the Quality of Dementia Care???????????????????????????????? (³¤¤òÆÉ¤à…)
Copyright(C) Ryomo Apotheker Network, All rights reserved, since 2004